Literature DB >> 15994466

Hepatocyte growth factor is required for alveologenesis in the neonatal rat.

Sanna Padela1, Judy Cabacungan, Samuel Shek, Rosetta Belcastro, Man Yi, Robert P Jankov, A Keith Tanswell.   

Abstract

RATIONALE: Our core hypothesis is that growth factors that have dysregulated expression during experimental neonatal lung injury are likely to be involved in normal postnatal lung growth and alveologenesis.
OBJECTIVES: To determine if hepatocyte growth factor (HGF) is upregulated in neonatal lung injury and is essential for postnatal alveologenesis.
METHODS: A neonatal lung injury, in which there were patchy areas of interstitial thickening with a relative increase in the proportion of epithelial cells, was induced in newborn rats by exposing them to 60% oxygen for 14 days. Air-exposed pups had binding of endogenous HGF to its natural receptor, c-Met, inhibited by the intraperitoneal injection of either neutralizing antibody to HGF, or a truncated soluble c-Met receptor.
MEASUREMENTS AND MAIN RESULTS: The 60% oxygen-mediated lung injury was associated with increased lung mRNAs for hepatocyte growth factor and c-Met, relative to air-exposed control lungs, at Day 7 after birth. After exposure to 60% oxygen, immunoreactive HGF was increased at Days 4 and 7, and immunoreactive c-Met was increased at Day 14. In air-exposed pups, intraperitoneal injections of neutralizing antibody to HGF inhibited DNA synthesis in alveoli-forming secondary crests, and reduced the number of alveoli in 6-day-old pups. Intraperitoneal injections of a truncated soluble c-Met receptor inhibited DNA synthesis in secondary crests in 4-day-old air-exposed rat pups.
CONCLUSIONS: HGF and its c-Met receptor are required for normal postnatal alveolar formation from secondary crests, and are upregulated during 60% oxygen-induced neonatal lung injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15994466     DOI: 10.1164/rccm.200504-567OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  7 in total

1.  Hyperoxia-derived lung damage in preterm infants.

Authors:  Vineet Bhandari
Journal:  Semin Fetal Neonatal Med       Date:  2010-04-28       Impact factor: 3.926

2.  Intermittent hypoxia during recovery from neonatal hyperoxic lung injury causes long-term impairment of alveolar development: A new rat model of BPD.

Authors:  Anastasiya Mankouski; Crystal Kantores; Mathew J Wong; Julijana Ivanovska; Amish Jain; Eric J Benner; Stanley N Mason; A Keith Tanswell; Richard L Auten; Robert P Jankov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-12-02       Impact factor: 5.464

Review 3.  Pleural mesothelial cells in pleural and lung diseases.

Authors:  Hitesh Batra; Veena B Antony
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

4.  Urokinase-type plasminogen activator increases hepatocyte growth factor activity required for skeletal muscle regeneration.

Authors:  Thomas H Sisson; Mai-Huong Nguyen; Bi Yu; Margaret L Novak; Richard H Simon; Timothy J Koh
Journal:  Blood       Date:  2009-10-07       Impact factor: 22.113

5.  TRPM7 channel inhibition exacerbates pulmonary arterial hypertension through MEK/ERK pathway.

Authors:  Junhui Xing; Mengyu Wang; Jin Hong; Yueqiao Gao; Yuzhou Liu; Heping Gu; Jianzeng Dong; Ling Li
Journal:  Aging (Albany NY)       Date:  2019-06-19       Impact factor: 5.682

6.  Endothelial HIF-2α as a Key Endogenous Mediator Preventing Emphysema.

Authors:  Shravani Pasupneti; Wen Tian; Allen B Tu; Petra Dahms; Eric Granucci; Aneta Gandjeva; Menglan Xiang; Eugene C Butcher; Gregg L Semenza; Rubin M Tuder; Xinguo Jiang; Mark R Nicolls
Journal:  Am J Respir Crit Care Med       Date:  2020-10-01       Impact factor: 30.528

7.  Pulmonary pericytes regulate lung morphogenesis.

Authors:  Katsuhiro Kato; Rodrigo Diéguez-Hurtado; Do Young Park; Seon Pyo Hong; Sakiko Kato-Azuma; Susanne Adams; Martin Stehling; Britta Trappmann; Jeffrey L Wrana; Gou Young Koh; Ralf H Adams
Journal:  Nat Commun       Date:  2018-06-22       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.